PB1926: REAL‐WORLD ERYTHROPOIESIS‐STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) by Mukherjee, S., Zimmerman Savill, K., Gajra, A., Kish, J., Brown‐Bickerstaff, C., Gentile, D., Falkenstein, A., Miller, T., Laney, J., McBride, A.

Get full text

Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 Rearrangement: A US Real-World Chart Review by Parasuraman, S, Saverno, K, Colucci, P, Kish, J, Zimmerman-Savill, K

Get full text

HSD91 Practice Patterns and Patient Management Techniques Utilizing Patient-Reported Outcomes Among Community Oncologists by Miller, T.A., Brown, M., Zimmerman Savill, K., Bone, R.N., Jeune-Smith, Y., Feinberg, B.

Get full text

HSD31 Real-World Pediatric Oncologist Utilization and Perceptions of Next Generation Sequencing by Garretson, M., Zimmerman Savill, K, Jeune-Smith, Y., Klink, A., Feinberg, B.

Get full text

HPR42 Transportation Barriers to Cancer Care: Perceptions Among U.S. Community Oncologists by John, W.S., Miller, T.A., Savill, K Zimmerman, Jeune-Smith, Y., Klink, A., Moffett, N., Feinberg, B.

Get full text

HSD7 Prescribing Behavior Among Community Oncologists for Generics/Biosimilars While Considering Costs or Financial Toxicity When Treating Cancer by Miller, T., Zimmerman Savill, K, Brown, M., Jeune-Smith, Y., Feinberg, B.

Get full text

RWD95 Comparing Representativeness of Race and Ethnicity in Real-World Evidence, Randomized Clinical Trial, and Surveillance, Epidemiology, and End Results (SEER) Cancer Patient Da... by Balanean, A., Gentile, D., Brown, M., Asgarisabet, P., Chopra, D., Swain, S., Schuler, T.A, Klink, A., Zimmerman Savill, K., John, W.S, Feinberg, B.

Get full text

RWD18 Age Comparisons across Real-World Evidence Research, Randomized Clinical Trials, and Surveillance, Epidemiology, and End Results (SEER) in Advanced Cancer by Schuler, T.A, Balanean, A., Asgarisabet, P., Gentile, D., Brown, M., Zimmerman Savill, K, Chopra, D., Klink, A., Swain, S., Feinberg, B.

Get full text

PT29 A Methodologic Solution to Missing Deauville Scores Using Imaging Report Data to Classify Lymphoma Treatment Response in Real-World Data by Swain, R, Savill KM, Zimmerman, Klink, A, Asgarisabet, P, Balanean, A, Hays, H, Kaufman, J, McAllister, L, Omary, C, Yu, HT, Kalesan, B, Laney, J, Feinberg, B

Get full text

CO201 Feasibility of Using Positron Emission Tomography–Computed Tomography (PET-CT) Scans From Real-World Medical Record Data to Support Lymphoma Treatment Response Assessment by Swain, R., Savill KM, Zimmerman, Klink, A., Asgarisabet, P., Balanean, A., Hays, H., Kaufman, J., McAllister, L., Omary, C., Yu, HT, Kalesan, B., Laney, J., Feinberg, B.

Get full text

MSR101 A Novel Methodology for Assessing Response to Lymphoma Treatment in Real-World Studies – the Real-World Lugano (RWLUGANO) Study by Swain, R, Savill KM, Zimmerman, Klink, A, Asgarisabet, P, Balanean, A, Hays, H, Kaufman, J, McAllister, L, Omary, C, Yu, HT, Kalesan, B, Laney, J, Richardson, N, Theoret, M, Lerro, C, Rizvi, F, Vallejo, J, Wang, K, Rivera, D, Feinberg, B

Get full text

Lower-Risk Myelodysplastic Syndromes: Erythropoiesis-Stimulating Agent Treatment Approaches and Outcomes in the United States by Zimmerman Savill, Kristin M., Gajra, Ajeet, Price, Kwanza, Kish, Jonathan K., Brown-Bickerstaff, Cherrishe, Falkenstein, Angelica, Miller, Talia, Laney, JaLyna, Mukherjee, Sudipto

Get full text